Skip to content
TheraProteins Phosphorylated N-linked oligosaccharides
Phosphorylated N-linked
 Phosphorylated  oligomannosidic or hybrid-type oligosaccharides present in recombinant therapeutic glycoproteins  (CHO, BHK and HEK cells) may target the drug to undesired cells or tissues when applied in patients. In order to avoid these risks, cells culture supernatant as well as drug substance should be controlled for the absence of this type of oligosaccharides. TheraProteins is worldwide the only company that offers a panel of this type of structures valuable in N-glycosylation mapping analysis of biopharmaceutical proteins at any stage of development.
Phosphorylated oligmannosidic (Man6GlcNAc2)
Phosphorylated oligmannosidic (Man5GlcNAc2)
Phosphorylated Hybrid type Galβ1-4GlcNAc(Man6GlcNAc2) plus proximal α1→ 6 Fucose
Phosphorylated Hybrid type Galβ1-4GlcNAc(Man6GlcNAc2)
Monosialylated Phosphorylated Hybrid type Galβ1-4GlcNAc(Man6GlcNAc2) plus proximal 1-6-link
Monosialylated Phosphorylated Hybrid type Galβ1-4GlcNAc(Man6GlcNAc2)